226 related articles for article (PubMed ID: 24818718)
1. The role of inflammation in colon cancer.
Janakiram NB; Rao CV
Adv Exp Med Biol; 2014; 816():25-52. PubMed ID: 24818718
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention for colon cancer: new opportunities, fact or fiction?
Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
4. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
[TBL] [Abstract][Full Text] [Related]
5. Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma.
Mandal P
Inflammopharmacology; 2018 Apr; 26(2):331-336. PubMed ID: 29289998
[TBL] [Abstract][Full Text] [Related]
6. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
7. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease and inflammation-associated colon cancer: partners in crime.
Danese S
Curr Drug Targets; 2008 May; 9(5):360. PubMed ID: 18473762
[No Abstract] [Full Text] [Related]
9. Inflammation and colon cancer.
Terzić J; Grivennikov S; Karin E; Karin M
Gastroenterology; 2010 Jun; 138(6):2101-2114.e5. PubMed ID: 20420949
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.
Urbanska AM; Zhang X; Prakash S
Cell Biochem Biophys; 2015 Jul; 72(3):757-69. PubMed ID: 27352189
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted link between cancer and inflammation.
Sethi G; Shanmugam MK; Ramachandran L; Kumar AP; Tergaonkar V
Biosci Rep; 2012 Feb; 32(1):1-15. PubMed ID: 21981137
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in sporadic colorectal cancer.
Moossavi S; Bishehsari F
Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
[TBL] [Abstract][Full Text] [Related]
13. Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices.
Velayos F
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):817-25. PubMed ID: 19090741
[TBL] [Abstract][Full Text] [Related]
14. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats.
Arigesavan K; Sudhandiran G
Biochem Biophys Res Commun; 2015 May; 461(2):314-20. PubMed ID: 25881504
[TBL] [Abstract][Full Text] [Related]
15. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer.
Atreya R; Neurath MF
Curr Drug Targets; 2008 May; 9(5):369-74. PubMed ID: 18473764
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.
Stolfi C; Fina D; Caruso R; Caprioli F; Sarra M; Fantini MC; Rizzo A; Pallone F; Monteleone G
Biochem Pharmacol; 2008 Feb; 75(3):668-76. PubMed ID: 17981262
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
18. Proteases and their receptors as mediators of inflammation-associated colon cancer.
Trusevych EH; MacNaughton WK
Curr Pharm Des; 2015; 21(21):2983-92. PubMed ID: 26004412
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer.
Talero E; Ávila-Roman J; Motilva V
Curr Pharm Des; 2012; 18(26):3939-65. PubMed ID: 22632755
[TBL] [Abstract][Full Text] [Related]
20. Intestinal inflammation and cancer.
Ullman TA; Itzkowitz SH
Gastroenterology; 2011 May; 140(6):1807-16. PubMed ID: 21530747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
